Skip to Main Content
Skip Nav Destination

The mechanisms underlying neurodegenerative diseases remain poorly understood, compromising the development of effective therapies. Chemical probes are useful tools to investigate the biological relevance of potential targets in cell-based disease models. This chapter reviews compounds that have emerged from cellular target-based and phenotypic screenings, focusing on Alzheimer's and Parkinson's diseases. Further, it makes recommendations on the use of good chemical probes that may help improve our understanding of neurodegeneration and serve as leads for therapeutic development.

You do not currently have access to this chapter, but see below options to check access via your institution or sign in to purchase.
Don't already have an account? Register
Close Modal

or Create an Account

Close Modal
Close Modal